Quadrant Private Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,056
| Closed | -$110K | – | 261 |
|
|
2022
Q4 | $110K | Buy |
+12,056
| New | +$110K | 0.04% | 237 |
|
|
2022
Q2 | $91K | Hold |
12,056
| – | – | 0.04% | 201 |
|
|
2022
Q1 | $113K | Sell |
12,056
-700
| -5% | -$6.56K | 0.04% | 202 |
|
|
2021
Q4 | $102K | Sell |
12,756
-1,600
| -11% | -$12.8K | 0.04% | 198 |
|
|
2021
Q3 | $140K | Sell |
14,356
-3,200
| -18% | -$31.2K | 0.06% | 187 |
|
|
2021
Q2 | $174K | Sell |
17,556
-3,200
| -15% | -$31.7K | 0.07% | 187 |
|
|
2021
Q1 | $240K | Sell |
20,756
-3,100
| -13% | -$35.8K | 0.1% | 168 |
|
|
2020
Q4 | $230K | Buy |
23,856
+1,100
| +5% | +$10.6K | 0.1% | 166 |
|
|
2020
Q3 | $205K | Sell |
22,756
-600
| -3% | -$5.41K | 0.1% | 164 |
|
|
2020
Q2 | $288K | Buy |
23,356
+4,800
| +26% | +$59.2K | 0.17% | 132 |
|
|
2020
Q1 | $167K | Buy |
+18,556
| New | +$167K | 0.14% | 139 |
|